Document ID: chunk:federal_register_of_legislation:F2024L01153:body:0:p14
Version: federal_register_of_legislation:F2024L01153
Segment Type: other
Provision Reference: 
Character Range: 37482–40969

any word or words having the same or similar effect; or
               (f) the abbreviations 'HMO' or HiMO' or any abbreviation having the same or similar effect; or
               (g) words claiming that the formula is suitable for all infants; or
               (h) information relating to the nutritional content of human milk; or
               (i) information relating to the presence of a substance listed in subsection (2), except for a reference in:
                   (i) a statement of ingredients; or
                   (ii) a declaration or statement expressly permitted or required by this Code; or
               (j) information relating to ingredients, except for:
                   (i) use of the word 'milk'; or
                   (ii) a reference in a statement of ingredients; or
                   (iii) a reference in a declaration or statement expressly permitted or required by this Code; or
               (k) information relating to the animal or plant source or sources of protein except:
                   (i) in a statement of ingredients; or
                   (ii) where required by subsection 2.9.1—20(1); or
               (l) the words 'partially hydrolysed' or any word or words having the same or similar effect, except:
                   (i) in a statement of ingredients; or
                   (ii) where required by subsection 2.9.1—20(2).

            (2) For the purposes of paragraph (1)(i), the following substances are listed:

               (a) an *inulin-type fructan; and
               (b) a *galacto-oligosaccharide; and
               (c) a nutrient; and
               (d) a substance *used as a nutritive substance'.

               Note Section 2.9.1—24 expressly requires or permits these substances to be declared or stated in the nutrition information statement required by that section.

           Division 4 Special medical purpose product for infants

           2.9.1—30 Application of other Standards

             Unless the contrary intention appears, the following provisions do not apply to a special medical purpose product for infants:

               (a) Part 1.2 of Chapter 1 (labelling and other information requirements); and
               (b) Division 3 of this Standard.

           2.9.1—31 Restriction on the sale of special medical purpose products for infants

            (1) A special medical purpose product for infants must not be sold to a consumer, other than from or by:

               (a) a medical practitioner or dietitian; or
               (b) a medical practice, pharmacy or *responsible institution; or
               (c) a majority seller of that special medical purpose product for infants.

            (2) In this section:

           majority seller means, in relation to a special medical purpose product for infants, a person who:

                   (a) during any 24 month period, sold that special medical purpose product for infants to any of the following:
                      (i) a medical practitioner;
                      (ii) a dietitian;
                      (iii) a medical practice;
                      (iv) a pharmacy;
                      (v) a *responsible institution; and
                   (b) the sales mentioned in paragraph (a) represent more than one half of the total amount of that special medical purpose product for infants sold by the person during that 24 month period.

            medical practitioner means a person registered or licensed as